StemCells Profile

0.02  1.59%
Last 1 Month(s)
Trading Day 

StemCells Summary

Please make sure the stock is currently traded on Nasdaq Capital Markets. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.

StemCells Inc Risk Profiles

Key Fundamentals

StemCells Against Markets

StemCells Leadership

Martin McGlynn CEO, Director, Member of Strategic Transactions Committee, CEO of Stemcells California Inc and President of Stemcells California Inc
John Schwartz Independent Chairman of the Board, Ph.D
More Executives

StemCells Diversification Suggestion

Use StemCells to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of StemCells to be traded at 1.408 in 30 days
  The entity StemCells Inc with a symbol STEM was delisted from Nasdaq Capital Markets. Please use Microbot Medical Inc with a symbol MBOT from now on.
StemCells Corporate Directors
Alan Trounson Director
Irving Weissman Director
Megan Meloni Director of Investor Relations and Corporate Communications
Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  
StemCells Earnings Estimates
StemCells Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate